Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 24.17 Billion | USD 69.75 Billion | 12.50% | 2023 |
The global proteomics market size was worth around USD 24.17 billion in 2023 and is predicted to grow to around USD 69.75 billion by 2032 with a compound annual growth rate (CAGR) of roughly 12.50% between 2024 and 2032.
The report covers a forecast and an analysis of the proteomics market on a global and regional level. The study provides historical data for 2019, 2020, and 2021 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints of the proteomics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the proteomics market on a global and regional level.
Proteomics is the comprehensive study of proteomes, which are basically a lot of proteins that are manufactured or altered by an organism or structure. Proteomics enables the identification of a vast number of proteins. The proteomes vary from cell to cell and deviate over time. Proteomics reveals substantial biological information that plays an important role in disease diagnosis and drug discovery. Developments in mass spectrometry, protein fractionation practices, and bioinformatics have increased the significance of proteomics. The use of proteomics has transformed drug discovery entirely. The analysis of transcription, side effect outlining, pharmacogenomics, and biomarker identification are vital in the process of drug discovery.
The growing demand for personalized medicines, increasing expenditure on research and development by the leading market players, various technological advancements, rising awareness regarding multiple applications of proteomics, increasing case of genetic disorders, the ability of proteomics to bridge the gap between cellular behavior and genome expression, and rapid implementation of latest technologies in developed regions are majorly driving the growth of the global proteomics market.
Governmental efforts to fast track research and development activities will create new opportunities for the market players in the global proteomics market in the years ahead. However, the high cost of instruments, the dearth of skilled research professionals, and lack of awareness regarding proteomics and its applications in developing regions may restrict the global proteomics market.
In order to give the users of this report a comprehensive view of the proteomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the proteomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the proteomics market on a global and regional basis.
Report Attributes | Report Details |
---|---|
Report Name | Proteomics Market Research Report |
Market Size in 2023 | USD 24.17 billion |
Market Forecast in 2032 | USD 69.75 billion |
Compound Annual Growth Rate | CAGR of 12.50% |
Number of Pages | 205 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Agilent Technologies, Thermo Fisher Scientific Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., GE Healthcare, Caprion Proteomics Inc., PerkinElmer, Inc., and Waters Corporation, among others. |
Segments Covered | By Component, By Application And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global proteomics market is split into component and application.
Based on the component, the proteomics market is segmented into reagents and instruments. The reagents segment held the largest market share in 2022, due to the rising product use for separation of protein from intricate mixtures and additional proteome investigation measures. Reagents are sub-segmented into spectroscopy, microarray, X-ray crystallography, electrophoresis, chromatography, protein fractionation reagents, immunoassay, and services. Instruments are sub-segmented into spectrometry, protein microarray, chromatography, surface plasmon resonance, electrophoresis, protein fractionation systems, and X-ray crystallography.
The application segment is divided into disease diagnosis, drug discovery, and others. Drug discovery held the largest market share in 2018, due to multiple advantages offered by proteomics technology in the drug discovery process.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with it's further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
By region, North America will be the leading region over the forecast time period in the global proteomics market. The growing implementation of tailored medicine, positive government initiatives, huge investments in research and development, increasing investments made by academic institutions in proteomics and genomics research, and the presence of the state-of-the-art healthcare facilities are driving the region’s proteomics market. Europe will be the second largest proteomics market globally in the future, owing to the presence of skilled researchers, high R&D investment made by leading companies, increasing geriatric population, the rising prevalence of chronic disorders, and positive reimbursement scenario.
The Asia Pacific proteomics market will grow at a speedy rate over the forecast time period due to the rising incidence of chronic diseases, growing interest in proteomics, increasing research and development on proteomics applications, and growing use of proteomics in disease diagnosis and therapy.
The global proteomics market is dominated by players like:
Global Proteomics Market: By Component
Global Proteomics Market: By Application
Global Proteomics Market: By Region
FrequentlyAsked Questions
Proteomics is the study of proteins on a massive scale, with an emphasis on their structures and functions. The process entails conducting a thorough examination of every protein found in a cell, tissue, or organism under particular circumstances; this collection is commonly known as the proteome. The fundamental objective of proteomics is to comprehend the manner in which proteins operate, interact, and are regulated within biological systems.
The ongoing advancements in chromatography and MS technologies have significantly improved the resolution, sensitivity, and throughput of proteomic analyses. The aforementioned developments empower scientists to conduct thorough and high-throughput protein identification, quantification, and characterization, thereby stimulating the expansion of the market.
The global proteomics market size was worth around USD 24.17 billion in 2023 and is predicted to grow to around USD 69.75 billion by 2032.
The global proteomics market with a compound annual growth rate (CAGR) of roughly 12.50% between 2024 and 2032.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with it's further divided into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some key players of the global proteomics market are Agilent Technologies, Thermo Fisher Scientific Corporation, Luminex Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., GE Healthcare, Caprion Proteomics Inc., PerkinElmer, Inc., and Waters Corporation, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed